GlassScriptPhysician profile
Alexander Javier Bolanos
NPI 1578900619
$9,715.15
in general payments reported to CMS, 2019-2025
31 companies · $664 in 2025
The $664 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,817 · 2020: $1,480 · 2021: $639 · 2022: $306 · 2023: $382 · 2024: $427 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,436 · Gift: $36.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.76 |
| Gift | $36.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,041.57 | 2019-2020 | |
| Abiomed | $1,751.36 | 2019-2024 | Impella |
| Abbott Laboratories | $1,388.99 | 2019-2023 | Diamondback Peripheral |
| Edwards Lifesciences Corporation | $549.78 | 2020-2021 | |
| Medtronic Vascular, INC. | $300.03 | 2019 | |
| Kestra Medical Technology Services, INC. | $297.31 | 2023-2025 | Assure Wcd |
| Amgen INC. | $271.17 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $228.51 | 2019-2020 | |
| Penumbra, INC. | $190.19 | 2020-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $184.79 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ge Healthcare | $173.70 | 2020 | |
| Janssen Pharmaceuticals, INC | $167.24 | 2019 | |
| Shockwave Medical, INC | $141.26 | 2025 | |
| Novartis Pharmaceuticals Corporation | $132.33 | 2019-2024 | |
| Cook Medical LLC | $118.55 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $113.65 | 2019 | |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Medtronic, INC. | $81.95 | 2024-2025 | Symplicity G3 |
| Astrazeneca Pharmaceuticals LP | $76.40 | 2019-2024 | Farxiga |
| Stryker Corporation | $58.68 | 2025 | Clottriever Bold Catheter, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kiniksa Pharmaceuticals International, Plc | $43.44 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $42.54 | 2019-2025 | Camzyos |
| Astellas Pharma US INC | $41.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.97 | 2023-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $34.68 | 2025 | Onpattro |
| Atricure, INC. | $33.77 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Biosense Webster, INC. | $29.95 | 2025 | Carto 3 |
| Cardiva Medical, INC. | $25.49 | 2024 | Cardiva Vascade 6/7f Vcs |
| Cvrx, INC. | $24.45 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.71 | 2023-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $15.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Bolanos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.